The 1 analysts offering 12-month price forecasts for Orgenesis Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +23.80% increase from the last price of 7.27.
The current consensus among 1 polled investment analysts is to Buy stock in Orgenesis Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.21
Reporting Date Jul 21
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.